Related by context. All words. (Click for frequent words.) 63 liposomal formulation 62 histone deacetylase HDAC inhibitor 62 mertansine 62 Guanilib 62 tafamidis 62 oral prodrug 62 Traficet EN 61 JAK inhibitor 61 histone deacetylase inhibitor 61 PrevOnco 61 Onalta ™ 61 mitogen activated ERK kinase 61 PDX pralatrexate 61 Trofex 61 Clofarabine 61 targeted radiotherapeutic 61 KNS # 61 Xanafide 61 proteasome inhibitor 61 Factor VIIa 60 Saforis 60 Panzem R 60 candidate deforolimus 60 novel histone deacetylase 60 Iluvien ® 60 ORE# 60 histamine dihydrochloride 60 Soliris eculizumab 60 MAGE A3 ASCI 60 ALN TTR# 60 AzaSite Plus 60 acetonide FA 60 vinorelbine tartrate 60 Squalamine 60 fluoropyrimidine 60 Dalbavancin 60 PNP inhibitor 60 LEP ETU 60 Soliris TM eculizumab 60 Anidulafungin 60 hoFH 60 ENMD # 60 Onconase 60 OvaRex R 60 PDE4 inhibitor 60 vidofludimus 60 fibrotic disease 60 Oracea TM 60 OHR/AVR# 59 pseudobulbar affect PBA 59 Arimoclomol 59 investigational humanized monoclonal antibody 59 vascular disrupting agent 59 orally bioavailable 59 herpetic keratitis 59 Combidex 59 PI3K/Akt pathway inhibitor 59 Firazyr 59 Iluvien TM 59 entinostat 59 Acute Radiation Syndrome ARS 59 Vilazodone 59 CINTREDEKIN BESUDOTOX 59 Liprotamase 59 Tyrima 59 MGCD# [001] 59 Plicera 59 Fodosine 59 investigational hepatitis C 59 triphendiol 59 Sphingomab 59 Davanat 59 Zenvia ™ 59 selective modulator 59 XL# XL# 59 Tarceva TM 59 UPLYSO 59 HCV protease inhibitor 59 HuMax CD4 59 Civacir 59 synthetic retinoid 59 anticancer compound 59 molecular imaging radiopharmaceutical 59 pexiganan 59 metaglidasen 59 pralatrexate 59 erlotinib Tarceva ® 59 pharmacological chaperone 59 Ferumoxytol 58 Rescula 58 Junovan 58 topically applied SEPA 58 IMA# 58 Curaxin CBLC# 58 reslizumab 58 Tarvacin TM 58 PEGylated 58 BNC# 58 Aplidin 58 Aviptadil 58 trastuzumab DM1 T DM1 58 targeting CD# 58 anti angiogenic agent 58 ZEVALIN ® 58 TG# [003] 58 tezampanel 58 INS# [001] 58 Optiquel ™ 58 IL# PE#QQR 58 fosbretabulin 58 tiapamil 58 CEQ# 58 JAK2 inhibitor 58 Ampligen ® 58 targeting PCSK9 58 Junovan TM 58 PSN# [002] 58 nucleoside analog 58 PrevOnco ™ 58 Anavex #-# 58 Lixivaptan 58 ALN TTR 58 generation purine nucleoside 58 Preclinical studies suggest 58 VitiGam 58 docetaxel Taxotere R 58 radiation sensitizer 58 Pruvel 58 sorafenib Nexavar 58 Chemophase 58 Symadex 58 ELACYT 58 CRMD# 58 cutaneous T 58 Silodosin 58 Troxatyl 58 iSONEP 58 ocular formulation 58 SinuNase TM 58 registrational 58 interferon gamma 1b 58 orally administered inhibitor 58 OMNARIS HFA 58 RECOTHROM R 58 BrachySil 58 small molecule tyrosine 58 PROVENGE ® 58 PLK1 SNALP 58 Insegia 58 Ampligen r 58 menadione 58 amrubicin 58 novel peptide 58 HSP# inhibitor 58 virus HCV protease inhibitor 58 volociximab 58 HQK 58 ASONEP 58 DOS# 58 INCB# [002] 57 iduronate 2 57 STEDESA 57 HDAC Inhibitor 57 OncoVEX 57 preclinical efficacy 57 rxRNA 57 ALN PCS 57 Ceflatonin 57 Phase Ib study 57 Intarcia 57 HepaGam B 57 Friedreich Ataxia FRDA 57 YONDELIS 57 Atiprimod 57 lexidronam injection 57 Maribavir 57 NEUMUNE 57 RhuDex ® 57 Unit Dose Budesonide 57 xanthine oxidase inhibitor 57 JAK1 57 phase IIa clinical 57 sodium thiosulfate STS 57 depsipeptide 57 Solazed TM 57 Zemiva TM 57 #ME# 57 chemotherapeutic drug 57 PD LID 57 nanopharmaceutical 57 Pemetrexed 57 TRIOLEX 57 intranasal formulation 57 Bortezomib 57 IgG1 monoclonal antibody 57 mTOR inhibitor 57 OncoVEX GM CSF 57 cetuximab Erbitux ® 57 vascular disrupting agents 57 alvespimycin 57 docetaxel Taxotere ® 57 SNT MC# 57 Carfilzomib 57 PANVAC VF 57 LEVADEX TM 57 Pimavanserin 57 RNAi therapeutic targeting 57 MEK inhibitors 57 Zybrestat 57 TELINTRA 57 SERMs 57 amphotericin B 57 anti amnesic 57 torezolid phosphate 57 adipiplon 57 Panzem NCD 57 forodesine 57 humanized monoclonal antibodies 57 Orphan Drug designations 57 MGd 57 tolevamer 57 Mipomersen 57 Onrigin 57 Voreloxin 57 Plenaxis TM 57 HspE7 57 PEGylated interferon 57 Androxal TM 57 SARMs 57 ARIKACE ™ 57 lucinactant 57 IRX 2 57 ISTODAX 57 Panzem 57 Perifosine 57 humanized monoclonal antibody 57 ketolide antibiotic 57 HCV protease inhibitors 57 BEMA TM Fentanyl 57 Carbamazepine 57 multi kinase inhibitor 57 HepeX B TM 57 Miraxion 57 Actimmune ® 57 Targretin 57 rilonacept 57 radiotherapeutic 57 methylnaltrexone 57 2 methoxyestradiol 57 dextromethorphan quinidine 57 alefacept 57 Regado 57 Phase III confirmatory 57 PXD# 57 Personalized Immunotherapy 57 Sudhir Agrawal D.Phil 57 forodesine hydrochloride 57 Vandetanib 57 therapeutic monoclonal antibody 57 Amplimexon 57 Emezine 57 oral JAK1 57 small molecule defensin 57 panitumumab Vectibix 56 receptor tyrosine kinase inhibitor 56 PRTX 56 enzastaurin 56 cisplatin carboplatin 56 Phase #b/#a clinical 56 thalidomide Thalomid 56 Dacogen injection 56 T Pred 56 oritavancin 56 proteasome inhibitors 56 secondary hyperparathyroidism 56 Nexavar ® 56 superficial bladder cancer 56 romidepsin 56 EP #R 56 Cintredekin Besudotox 56 Proxinium TM 56 imatinib mesylate 56 CGEN # 56 TREANDA 56 Safinamide 56 DB# [003] 56 Ampligen R 56 neuroprotective properties 56 TLK# 56 anti CD3 56 Gleevec imatinib mesylate 56 alvimopan 56 IAP inhibitors 56 Homspera 56 oral antiviral 56 Liposomal 56 bortezomib Velcade ® 56 preclinical studies 56 DAVANAT 56 favorable pharmacokinetic profile 56 Panzem R NCD 56 NGX# 56 NEUGENE antisense 56 anti CD3 antibody 56 RenaZorb TM 56 Kamada AAT 56 peripherally acting 56 TYZEKA 56 BrachySil ™ 56 immune modulatory 56 isoform selective 56 Azedra ™ 56 gastrointestinal disorders characterized 56 Nexavar sorafenib 56 investigational antiplatelet agent 56 CCR5 antagonist 56 AAG geldanamycin analog 56 TLR9 agonists 56 Cethromycin 56 alemtuzumab MS 56 cell lymphoma CTCL 56 autologous cellular immunotherapy 56 Onalta 56 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 56 vapreotide acetate 56 R sorafenib tablets 56 liprotamase 56 phase IIb clinical 56 LPM TM 56 Dyloject TM 56 SUTENT ® 56 gastrointestinal stromal tumor 56 Leukine ® 56 non alcoholic steatohepatitis 56 Amigal 56 malignant ascites 56 URG# 56 REOLYSIN ® 56 MEK inhibitor 56 mifamurtide 56 KRN# 56 Erlotinib 56 Familial Adenomatous Polyposis FAP 56 ONCONASE R 56 HDL Mimetic Peptide 56 riociguat 56 anti angiogenic agents 56 TRO# 56 Clevudine 56 Avicena 56 postoperative ileus 56 PF # [002] 56 obatoclax 56 BrachySil TM 56 nephropathic cystinosis 56 VAPRISOL 56 lumiliximab 56 Mirapexin 56 aldehyde dehydrogenase ALDH2 deficiency 56 Interferon alpha 56 bortezomib Velcade 56 ara C 56 investigational pan BCR 56 multitargeted 56 Cerashield 56 Gleevec resistant 56 iroxanadine 56 lorvotuzumab mertansine 56 FOLOTYN ® 56 S1P antibody 56 Exelixis compounds 56 Intravenous Human 56 Linaclotide 56 Cloretazine R 56 PS# [001] 56 silodosin 56 Tolevamer 56 antiangiogenic agent 56 Revimmune 56 Iloperidone 56 alkylating agent 56 KRYSTEXXA TM pegloticase 56 PTH analogue 56 QLT# 56 SinuNase ™ 56 ocular inflammatory 56 Exherin TM 56 immunotherapeutic 56 ALGRX 56 Lenocta 56 VALSTAR 56 selective androgen receptor modulator 56 Virulizin ® 56 vaccine adjuvant 56 adecatumumab MT# 56 Phase Ib clinical 56 amifampridine phosphate 56 PEG SN# 56 recurrent glioblastoma multiforme 56 CIP TRAMADOL ER 56 Qutenza TM 56 polycythemia vera PV 56 systemic anaplastic large 56 opioid induced constipation 56 Hedgehog pathway inhibitor 56 otelixizumab 56 relapsed leukemia 56 OXi# 56 BAY #-# 56 Cleviprex TM clevidipine 56 investigational monoclonal antibody 56 small molecule chemotherapeutic 56 somatostatin analogues 56 rhIGF-I/rhIGFBP-3 56 ADVEXIN 56 cysteamine 56 CYT# potent vascular disrupting 56 RG# [001] 56 Nexavar tablets 56 Kuvan sapropterin dihydrochloride 56 SPRYCEL ® 56 anticancer agent 56 potent anticancer 56 Fc fusion protein 55 6R BH4 55 hormone LHRH antagonist 55 hypoxia activated prodrug 55 Darinaparsin 55 mRCC 55 Thiovir 55 neuro inflammatory 55 delivers fluocinolone acetonide FA 55 Serdaxin 55 Romidepsin 55 NovaBay Aganocide compounds 55 PRT# 55 Tolvaptan 55 Azedra 55 immuno modulatory 55 MAP# 55 DAVANAT R 55 Genasense ® 55 Abiraterone acetate 55 Cloretazine R VNP#M 55 G#DT 55 Archexin 55 demonstrated antitumor activity 55 chorea associated 55 cediranib 55 OvaRex ® MAb 55 immune modulating 55 antibody MAb 55 Diabetic Macular Edema 55 Janus kinase 55 adenosine A2A 55 Bioral ® 55 HuLuc# 55 SYN# 55 Noxafil 55 Reolysin 55 huC# DM4 55 pharmacokinetic PK study 55 tanespimycin 55 carcinoid syndrome 55 IAP inhibitor 55 Janus Kinase 55 atypical hemolytic uremic syndrome 55 Cotara R 55 Cloretazine ® 55 EVIZON ™ 55 Aflibercept 55 subcutaneous formulation 55 Evoltra ® 55 Enkephalin 55 mesylate 55 erlotinib Tarceva 55 Angiolix 55 telomerase inhibitor drug 55 cutaneous T cell 55 ONGLYZA ™ 55 Phase IIb clinical trials 55 Crofelemer 55 ATL# [002] 55 Telatinib 55 MAXY G# 55 telomerase therapeutic 55 treating neuropathic pain 55 DFMO 55 CCR9 antagonist 55 GRNVAC1 55 thymalfasin 55 SIR Spheres 55 cetuximab Erbitux R 55 psoriasis rheumatoid arthritis 55 radiolabeled TM# 55 arterial thrombosis 55 Zerenex 55 DPX Survivac 55 Doxorubicin 55 Cardio Vascu Grow 55 NTDDS 55 acyclovir Lauriad R 55 myelofibrosis 55 BLP# Liposome Vaccine 55 TRISENOX ® 55 Aerosurf 55 anti CD3 monoclonal 55 Fabry Disease 55 Linjeta TM 55 Apoptone 55 Cethrin 55 Tasimelteon 55 AP# [003] 55 Gemzar ® 55 Curaxin 55 LymphoStat B TM 55 non resectable 55 Carbaglu 55 CA4P 55 casopitant 55 visilizumab 55 Mitoxantrone 55 calcineurin inhibitors 55 Bicifadine 55 oral mucositis 55 pan HDAC inhibitor 55 Urocidin 55 farletuzumab 55 Viprinex 55 myelofibrosis polycythemia vera 55 tizanidine hydrochloride short 55 taxane chemotherapy 55 Bendavia 55 non nucleoside HCV 55 Amrubicin 55 Cellegesic 55 octreotide implant 55 pemetrexed Alimta 55 BiovaxID TM 55 deferiprone 55 Ecallantide 55 Romiplostim 55 Hsp# Inhibitor 55 Levoleucovorin 55 OPAXIO 55 Oral NKTR 55 Phase 2a clinical 55 XmAb# 55 Homspera TM 55 HDACi 55 PSN# [001] 55 TAFA# 55 EOquin 55 ProMune 55 Pegloticase 55 Resten NG 55 KL4 surfactant 55 prokinetic agent 55 organ transplant rejection 55 CCX# 55 Pralatrexate 55 LE DT 55 VEGF inhibitors 55 Navelbine ® 55 personalized immunotherapy 55 TRANSDUR Bupivacaine 55 EFAPROXYN 55 Radezolid 55 CYT# 55 AzaSite Xtra 55 EVIZON TM squalamine lactate 55 ProLindac TM 55 induced macular edema 55 Folotyn 55 ATL# [001] 55 Octreotide 55 refractory gout 55 Valortim ® 55 ZFP Therapeutic 55 Linjeta ™ 55 PKC# 55 Cloretazine 55 TBC# 55 selective inhibition 55 RAV# 55 trabectedin 55 CDP# 55 immunomodulatory 55 Cannabinor 55 Gliadel Wafer 55 VQD 55 Xcytrin R 55 Initiates Phase II 55 monoclonal antibody conjugated 55 MKC# PP 55 AEGR 55 Dasatinib 55 Genasense ® oblimersen 55 Rasagiline 55 Hedgehog Pathway Inhibitor 55 TYSABRI natalizumab 55 injectable formulation 55 Pazopanib 55 KIACTA ™ 55 microsphere therapy 55 thetreatment 55 novel VDA molecule 55 INCB# [001] 55 nanoviricide 55 PROCHYMAL 55 CTAP# Capsules 55 bleomycin 55 Alinia 55 L BLP# 55 TheraSphere 55 CBLC# 55 ATPace TM 55 immune stimulatory 55 HP Acthar Gel repository 55 murine model 55 Annamycin 55 SYCREST 55 neuroprotectant 55 Uricase PEG 55 ropinirole Requip 55 ALN HTT 55 Zingo TM 55 Prodarsan ® 55 palifosfamide 55 NEUGENE 55 Dapagliflozin 55 Galantamine 55 PHX# 55 Fludara ® 55 Bezielle 55 TLR8 agonist 55 neratinib 55 Fibrillex TM 55 lysosomal storage diseases 54 BLA filing 54 Sym# 54 Aganocide 54 WX UK1 54 acyclovir Lauriad ® 54 Asentar 54 HCV polymerase inhibitor 54 Mepact 54 Chemokine Receptor 54 Deferiprone 54 humanized anti 54 AKT inhibitor 54 balsalazide tablet 54 CCR2 54 GVAX ® 54 preclinical 54 non metastatic osteosarcoma 54 ibudilast 54 refractory chronic lymphocytic 54 Zalypsis 54 Trofex ™ 54 Glufosfamide 54 Initiate Clinical Trial 54 Harry Palmin President 54 mycosis fungoides 54 cleavable linker 54 lomitapide 54 defensin mimetic antibiotic 54 Fx #A 54 pain palliation 54 Prodarsan R 54 AEG# 54 ICA # 54 methylnaltrexone bromide 54 Lenalidomide 54 erythropoietic 54 RNAi therapeutic 54 ON #.Na 54 HGS ETR1 54 refractory APL 54 Thrombin topical Recombinant 54 HoFH 54 diarrhea predominant irritable 54 deforolimus 54 Multimeric 54 gefitinib Iressa 54 Neuradiab 54 TKM Ebola 54 Anturol ® 54 schizophrenia CIAS 54 Cerepro ® 54 vemurafenib 54 SNALP technology 54 PCK# 54 exon skipping 54 ZYBRESTAT 54 systemic juvenile idiopathic 54 Phase Ib clinical trials 54 Golimumab 54 benign prostatic hypertrophy BPH 54 aripiprazole Abilify 54 PLX cells 54 cancer immunotherapies 54 Valortim 54 intravenously administered 54 Ceflatonin R 54 Omacetaxine 54 GSK# [001] 54 eltrombopag 54 temsirolimus Torisel ® 54 polyclonal antibody 54 EGS# 54 overactive bladder AA# 54 immuno oncology 54 tyrosine kinase inhibitors TKIs 54 bevacizumab Avastin R 54 talactoferrin 54 dermal patch 54 BENLYSTA ® 54 Microplasmin 54 granulated mesalamine 54 Relivar 54 DermaVir Patch 54 Pafuramidine 54 Hyphanox 54 Kevetrin ™ 54 orally inhaled migraine 54 refractory acute myeloid 54 zolpidem tartrate sublingual tablet 54 Omapro 54 Onco TCS 54 orally dosed 54 non nucleoside inhibitor 54 RhuDex 54 Nanobody 54 XL# anticancer compounds 54 rifalazil 54 antitumoral 54 dasatinib Sprycel ® 54 aurora kinase 54 ATryn ® 54 fibrotic diseases 54 bevacizumab Avastin ® 54 nucleotide analog 54 FluCide 54 NexACT 54 receptor agonists 54 samarium Sm 54 BRAF inhibitor 54 essential thrombocythemia ET 54 MyVax R 54 Completes Patient Enrollment 54 pediatric Crohn disease 54 Azixa 54 Vinorelbine 54 Phase IIa clinical 54 Cand5 54 lenalidomide Revlimid R 54 VNP#M 54 MEK inhibitor RDEA# 54 GED aPC 54 Spiegelmer ® 54 Irinotecan 54 Daclizumab 54 oral nucleoside analogue 54 Corlux 54 investigational oral hepatitis C 54 JAK2 Inhibitor 54 JAK inhibitors 54 Carbidopa 54 Premarket Approval PMA 54 Simulect 54 Vaprisol 54 Collategene 54 Biologics License Application 54 intravenous acetaminophen 54 Arikace 54 FK# 54 neuropathy sparing 54 selective A2A adenosine receptor 54 Alzhemed TM 54 Arcalyst 54 SURFAXIN 54 R#/MEM # 54 colorectal liver metastases 54 PI3K inhibitor 54 Catena ® 54 Phase 2a 54 vinorelbine 54 topical anti infective 54 Immunotherapeutic 54 ZOLINZA 54 ARRY # 54 JAK2 inhibitors 54 MOVIPREP R 54 Shigamabs R 54 Ozurdex 54 sulodexide 54 Zevalin R Ibritumomab 54 Natalizumab 54 Roflumilast 54 sorafenib tablets 54 PROVENGE sipuleucel T 54 huN# DM1 54 Indaflex TM 54 TRX1 54 brostallicin 54 ADVEXIN clinical 54 BAL# [002] 54 BCG refractory carcinoma 54 Aryplase 54 HGS ETR2 54 Synavive 54 Certolizumab pegol 54 ruxolitinib 54 ACV1 54 Urocidin TM 54 inhaled liposomal ciprofloxacin 54 HepeX B 54 vinca alkaloid 54 brivaracetam 54 Alvesco R 54 phase 2a 54 hematological cancers 54 cilengitide 54 plasma kallikrein inhibitor 54 GRN#L 54 chronic neuropathic pain 54 novel mTOR inhibitor 54 lesinurad 54 Satraplatin 54 ISIS # 54 Posiphen TM 54 oncolytic virus 54 EVIZON TM 54 Cinryze ™ 54 renal anemia 54 Restanza 54 evaluating satraplatin 54 corticotropin injection 54 SMT C# 54 drug ISA# 54 Diabetic Macular Edema DME 54 GLP1 INT TM 53 phase Ib 53 TRV# [001] 53 gemcitabine Gemzar ® 53 FOLFOX6 chemotherapy regimen 53 APOPTONE 53 Nimotuzumab 53 Oxaliplatin 53 phosphate binder 53 Entereg TM 53 novel therapeutic antibodies 53 unoprostone isopropyl 53 crofelemer 53 AA amyloidosis 53 IL# PE 53 Zelrix 53 potently inhibit 53 tubulin inhibitor 53 ATL/TV# 53 cannabinor 53 sunitinib malate 53 L DOS# 53 CORT # 53 pouchitis 53 modified glutathione analog 53 SomatoKine 53 LHRH antagonist 53 Shigamabs ® 53 eniluracil 53 Li Fraumeni Syndrome 53 Vicinium TM 53 PolyActive ® 53 Leber Hereditary Optic Neuropathy 53 ABL inhibitor 53 hematologic disorders 53 Orathecin 53 lysosomal storage disorder 53 anidulafungin 53 Phase IIb III 53 Clolar ® 53 Oral Spray 53 OncoGel 53 XP# XP# 53 HuMax EGFr 53 Surfaxin LS 53 antibody MT# 53 EOquin TM 53 rNAPc2 53 Vidofludimus 53 Triolex 53 HCV protease 53 Myocet 53 investigational 53 indibulin 53 Protexia R 53 immunomodulator 53 Anturol 53 esophageal candidiasis 53 MDV# 53 elotuzumab 53 anti fibrotic 53 diabetic neuropathic pain 53 axitinib 53 Panzem ® 53 docetaxel Taxotere 53 Hsp# inhibition 53 Rilonacept 53 atacicept 53 kidney urologic 53 Cetrorelix 53 Phenoptin 53 leukemia AML 53 Vivecon 53 evaluating picoplatin 53 MELAS 53 opioid induced constipation OIC 53 SILENOR 53 ixabepilone 53 Anticalin R 53 INSPIRE Trial Phase III 53 noninfectious uveitis 53 Velcade bortezomib 53 diabetic gastroparesis 53 zanolimumab 53 Loxapine 53 tyrosine kinase inhibitor 53 BiTE antibody 53 APEX PD 53 ADVANCE PD 53 Pirfenidone 53 ILUVIEN ® 53 Eculizumab 53 ongoing Phase 1b 53 PDE4 inhibitors 53 faropenem medoxomil 53 protein kinase inhibitor 53 pancreatic insufficiency 53 solid tumors 53 PDE7 inhibitors 53 Orphan Status 53 chemotherapeutics 53 seliciclib CYC# 53 iobenguane 53 AZILECT R 53 Recombinant Human 53 Anti VEGF 53 telaprevir VX 53 peritumoral brain edema 53 tiuxetan 53 ponatinib 53 photodynamic therapy PDT 53 Tamibarotene 53 LE SN# 53 p# inhibitor 53 eprotirome 53 TEMODAL 53 Advexin 53 bafetinib 53 Entereg R 53 interferon IFN 53 siRNA therapeutic 53 ORENCIA R 53 ABRAXANE ® 53 PIX# trial 53 RAPAFLO 53 dirucotide 53 metastatic malignant 53 H#N# VLP vaccine 53 lintuzumab 53 sapropterin dihydrochloride 53 IMiDs R 53 TTR amyloidosis 53 ibritumomab tiuxetan 53 AA Amyloidosis 53 Biologic License Application BLA 53 TRISENOX 53 Phase #b/#a trial 53 NeuroVax TM 53 Enzastaurin 53 IND submission 53 Allovectin 7 53 potassium binder 53 adalimumab Humira 53 TELCYTA 53 evaluating tivozanib 53 Chrysalin 53 ADVEXIN p# therapy 53 Transdel TM 53 BCG refractory 53 bevasiranib 53 FDA Approvable Letter 53 MyVax ® 53 TKM ApoB 53 PROSTASCINT R 53 Radilex 53 selective immunoproteasome inhibitor 53 antisense inhibitors